《2020中国系统性红斑狼疮诊疗指南》解读

2022-01-15 浙江省人民医院 浙江医学

系统性红斑狼疮(SLE)是一种典型的自身免疫性疾病,临床表现复杂且异质性大,需根据疾病活动度及受累器官的类型和严重程度制定个体化的治疗方案。《2020中国系统性红斑狼疮诊疗指南》的发布,有利于临床更加

中文标题:

《2020中国系统性红斑狼疮诊疗指南》解读

发布机构:

浙江省人民医院

发布日期:

2022-01-15

简要介绍:

系统性红斑狼疮(SLE)是一种典型的自身免疫性疾病,临床表现复杂且异质性大,需根据疾病活动度及受累器官的类型和严重程度制定个体化的治疗方案。《2020中国系统性红斑狼疮诊疗指南》的发布,有利于临床更加科学而规范地进行疾病管理,达到改善长期预后的效果。现对该指南进行解读,以期帮助临床医师更好、更加贴切地掌握SLE的临床诊治和管理技术。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=《2020中国系统性红斑狼疮诊疗指南》解读.pdf)] GetToolGuiderByIdResponse(projectId=1, id=bd5631c002366574, title=《2020中国系统性红斑狼疮诊疗指南》解读, enTitle=, guiderFrom=浙江医学, authorId=0, author=, summary=系统性红斑狼疮(SLE)是一种典型的自身免疫性疾病,临床表现复杂且异质性大,需根据疾病活动度及受累器官的类型和严重程度制定个体化的治疗方案。《2020中国系统性红斑狼疮诊疗指南》的发布,有利于临床更加, cover=, journalId=0, articlesId=null, associationId=2466, associationName=浙江省人民医院, associationIntro=浙江省人民医院(杭州医学院附属人民医院)风湿免疫科, copyright=0, guiderPublishedTime=Sat Jan 15 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">系统性红斑狼疮(SLE)是一种典型的自身免疫性疾病,临床表现复杂且异质性大,需根据疾病活动度及受累器官的类型和严重程度制定个体化的治疗方案。《2020中国系统性红斑狼疮诊疗指南》的发布,有利于临床更加科学而规范地进行疾病管理,达到改善长期预后的效果。现对该指南进行解读,以期帮助临床医师更好、更加贴切地掌握SLE的临床诊治和管理技术。&nbsp;</span></p>, tagList=[TagDto(tagId=648, tagName=系统性红斑狼疮)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21023, categoryName=赛诺菲-赛能, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7832, appHits=556, showAppHits=0, pcHits=2403, showPcHits=7270, likes=2, shares=65, comments=7, approvalStatus=1, publishedTime=Sat Feb 26 15:34:00 CST 2022, publishedTimeString=2022-01-15, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Feb 25 22:40:28 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 20:28:18 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=《2020中国系统性红斑狼疮诊疗指南》解读.pdf)])
《2020中国系统性红斑狼疮诊疗指南》解读.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2112542, encodeId=204c21125425a, content=👏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93055321194, createdName=148ab84am90暂无昵称, createdTime=Wed Feb 01 10:43:10 CST 2023, time=2023-02-01, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1234681, encodeId=cbc41234681b7, content=没有分是不是不能下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b4b5729687, createdName=ms1000002014403814, createdTime=Mon Jul 25 19:28:02 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221730, encodeId=b8001221e307e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210916/ea02a1a001f94f449da6ddaf4d96a56b/dfc31aa10153473eab2579b430bf74fc.jpg, createdBy=b5382547732, createdName=酥荒, createdTime=Mon May 23 11:39:10 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197784, encodeId=360d119e7848d, content=🎉, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2f62447791, createdName=123eb03dm66(暂无昵称), createdTime=Sun Feb 27 17:39:46 CST 2022, time=2022-02-27, status=1, ipAttribution=)]
    2023-02-01 148ab84am90暂无昵称 来自云南省

    👏

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2112542, encodeId=204c21125425a, content=👏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93055321194, createdName=148ab84am90暂无昵称, createdTime=Wed Feb 01 10:43:10 CST 2023, time=2023-02-01, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1234681, encodeId=cbc41234681b7, content=没有分是不是不能下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b4b5729687, createdName=ms1000002014403814, createdTime=Mon Jul 25 19:28:02 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221730, encodeId=b8001221e307e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210916/ea02a1a001f94f449da6ddaf4d96a56b/dfc31aa10153473eab2579b430bf74fc.jpg, createdBy=b5382547732, createdName=酥荒, createdTime=Mon May 23 11:39:10 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197784, encodeId=360d119e7848d, content=🎉, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2f62447791, createdName=123eb03dm66(暂无昵称), createdTime=Sun Feb 27 17:39:46 CST 2022, time=2022-02-27, status=1, ipAttribution=)]
    2022-07-25 ms1000002014403814

    没有分是不是不能下载

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2112542, encodeId=204c21125425a, content=👏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93055321194, createdName=148ab84am90暂无昵称, createdTime=Wed Feb 01 10:43:10 CST 2023, time=2023-02-01, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1234681, encodeId=cbc41234681b7, content=没有分是不是不能下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b4b5729687, createdName=ms1000002014403814, createdTime=Mon Jul 25 19:28:02 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221730, encodeId=b8001221e307e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210916/ea02a1a001f94f449da6ddaf4d96a56b/dfc31aa10153473eab2579b430bf74fc.jpg, createdBy=b5382547732, createdName=酥荒, createdTime=Mon May 23 11:39:10 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197784, encodeId=360d119e7848d, content=🎉, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2f62447791, createdName=123eb03dm66(暂无昵称), createdTime=Sun Feb 27 17:39:46 CST 2022, time=2022-02-27, status=1, ipAttribution=)]
    2022-05-23 酥荒

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2112542, encodeId=204c21125425a, content=👏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93055321194, createdName=148ab84am90暂无昵称, createdTime=Wed Feb 01 10:43:10 CST 2023, time=2023-02-01, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1234681, encodeId=cbc41234681b7, content=没有分是不是不能下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b4b5729687, createdName=ms1000002014403814, createdTime=Mon Jul 25 19:28:02 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221730, encodeId=b8001221e307e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210916/ea02a1a001f94f449da6ddaf4d96a56b/dfc31aa10153473eab2579b430bf74fc.jpg, createdBy=b5382547732, createdName=酥荒, createdTime=Mon May 23 11:39:10 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197784, encodeId=360d119e7848d, content=🎉, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2f62447791, createdName=123eb03dm66(暂无昵称), createdTime=Sun Feb 27 17:39:46 CST 2022, time=2022-02-27, status=1, ipAttribution=)]